Adulteration and poor quality of Ginkgo biloba supplements

Journal of Herbal Medicine

Volumn 6, Issue 2, 2016, Pages 79-87

  Booker, Anthony ^a,d   Frommenwiler, Debora ^b   Reich, Eike ^b   Horsfield, Samuel ^a,c   Heinrich, Michael ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b CAMAG Laboratory   (Switzerland)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; CHLOROGENIC ACID; DRUG METABOLITE; GINKGO BILOBA EXTRACT; KAEMPFEROL; QUERCETIN; RUTOSIDE;

ANALYTIC METHOD; ARTICLE; DIETARY SUPPLEMENT; DRUG CONTAMINATION; DRUG QUALITY; GINKGO BILOBA; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLANT LEAF; PRIORITY JOURNAL;

EID: 84964701655     PISSN: 22108033     EISSN: 22108041     Source Type: Journal    
DOI: 10.1016/j.hermed.2016.04.003     Document Type: Article

References (15)

1. Abad, M.J., Bedoya, L.M., Bermejo, P., An update on drug interactions with the herbal medicine Ginkgo biloba. Curr. Drug Metab. 11:2 (2010), 171–181.
2. Avula, B., Sagi, S., Gafner, S., Upton, R., Wang, Y.H., Wang, M., Khan, I.A., Identification of Ginkgo biloba supplements adulteration using high performance thin layer chromatography and ultra high performance liquid chromatography-diode array detector-quadrupole time of flight-mass spectrometry. Anal. Bioanal. Chem. 407:25 (2015), 7733–7746.
3. Booker, A., Jalil, B., Frommenwiler, D., Reich, E., Zhai, L., Kulic, Z., Heinrich, M., The authenticity and quality of Rhodiola rosea products. Phytomedicine, 2015.
4. Chandra, A., Li, Y., Rana, J., Persons, K., Chung, H., Shen, S., Mulder, T., Qualitative categorization of supplement grade Ginkgo biloba leaf extracts for authenticity. J. Funct. Foods 3:2 (2011), 107–114.
5. Daniells, S., Ginkgo adulteration is very widespread, say industry experts, so why is awareness low?. Breaking News on Supplements and Nutrition? North America, 2013, William Reed Business Media, NUTRA ingredients-USA.com.
6. Ding, S., Dudley, E., Plummer, S., Tang, J., Newton, R.P., Brenton, A.G., Quantitative determination of major active components in Ginkgo biloba dietary supplements by liquid chromatography/mass spectrometry. Commun. Mass Spectrom. 20 (2006), 2753–2760.
7. European Pharmacopoeia, 8th edition. Strasbourg (France): Directorate for the Quality of Medicines and HealthCare of the Council of Europe (EDQM); 2014.
8. Edwards, S., da Costa-Rocha, I., Williamson, E.M., Heinrich, M., Phytopharmacy—An Evidence-based Guide to Herbal Medicines. 2015, Wiley, Chichester.
9. Heinrich, M., Quality and safety of herbal medical products: regulatory opportunities and metabolomics approaches in quality assurance. Br. J. Clin. Pharmacol. 80:1 (2015), 62–66.
10. López-Gutiérrez, N., Romero-González, R., Vidal, J.L.M., Frenich, A.G., Quality control evaluation of nutraceutical products from Ginkgo biloba using liquid chromatography coupled to high resolution mass spectrometry. J. Pharm. Biomed. Anal. 121:2016 (2016), 151–160.
11. Liu, X.G., Wu, S.Q., Li, P., Yang, H., Review Advancement in the chemical analysis and quality control of flavonoid in Ginkgo biloba. J. Pharm. Biomed. Anal. 113 (2015), 212–225.
12. Shyur, L.-F., Yang, N.-S., Metabolomics for phytomedicine research and drug development. Curr. Opin. Chem. Biol. 12 (2008), 66–71.
13. USP, 39 United States Pharmacopeial Convention. United States Pharmacopeia and the National Formulary (USP 39—NF 34). Rockville (MD): The United States Pharmacopeial Convention, 2015.
14. Wohlmuth, H., Savage, K., Dowell, A., Mouatt, P., Adulteration of Ginkgo biloba products and a simple method to improve its detection. Phytomedicine 21 (2014), 912–918.
15. 1H NMR metabolomics reveals extensive metabolic reprogramming of primary and secondary metabolism in elicitor-treated opium poppy cell cultures. BMC Plant Biol., 8(5), 2008.